Since Maneatis et al. reported the low incidence of 27 per 100,000 patients receiving GHT developing CTS in 2000, the literature has shown significant increases in CTS in individuals receiving hormonal replacement therapy and in those with acromegaly, a state of endogenous GH overproduction [63,64,65]. Here, GH1 is linked to carpal tunnel syndrome.